by Co-Diagnostics | Oct 31, 2017 | News Release
SANDY, Utah–(BUSINESS WIRE)–Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, proprietary platform for the development of molecular diagnostics, announced today that its tests for Zika virus, tuberculosis, and other diseases will be...
by Co-Diagnostics | Oct 16, 2017 | News Release
SANDY, Utah–(BUSINESS WIRE)–Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, proprietary platform for the development of molecular diagnostics, announced today upcoming meetings with the Ministry of Public Health and Social...
